Michael John McKenna - Feb 15, 2022 Form 4 Insider Report for Akouos, Inc. (AKUS)

Role
Chief Medical Officer
Signature
/s/ Karoline Shair, as attorney-in-fact for Michael John McKenna
Stock symbol
AKUS
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4
Date filed
2/17/2022, 04:18 PM
Next filing
Dec 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKUS Stock Option (right to buy) Award $0 +90K $0.00 90K Feb 15, 2022 Common Stock 90K $5.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option will vest on February 15, 2023 and the balance will vest in equal monthly installments over the following 36 months.